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ABSTRACT 
In developing and developed countries, cancer is a significant health problem in people. Cancer becomes the second greatest cause of death in 
human after cardiovascular disease. However, significant advancements in modern cancer therapies have a beneficial impact on survival, 
chemotherapy and radiation therapy. Plants fulfill our basic needs to continue life and provide natural products that help to cure disease. The 
medicinal plants are readily available and have no toxicity as compared to modern drugs. Phytochemicals act on metabolic pathways and inhibit 
tumor growth, the development of cancerous cells, and replication by different mechanisms. Apigenin's chemo-preventive and anticancer activities 
have been demonstrating in numerous studies. Curcumin is a polyphenolic compound isolated from the Curcuma longa plant. EGCG, a polyphenol in 
black, white, and green tea is a chemo-preventive effect against many cancers by targeting multiple pathways. Normal cell growth and cell 
proliferation are closely regulated processes. The JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway controls gene 
expression during different processes, including proliferation, initiation, and apoptosis. The transcription factors are associated with the growth of 
cancer cells and control a cellular function in the disease. Mitogen-activated protein kinase (MAPK) is a class of serine and threonine kinase that 
includes ERK (extracellular regulated kinase), JNK (c-Jun N-terminal kinases), and p38. This review paper describes natural phytochemical 
compounds, their molecular targets and mechanisms of action. 
Keywords: Cancer, Medicinal plants, Phytochemicals, Signaling pathways 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) 
DOI: https://dx.doi.org/10.22159/ijpps.2021v13i12.42798. Journal homepage: https://innovareacademics.in/journals/index.php/ijpps.  
 
INTRODUCTION 
Hippocrates, a Greek physician, was the first to name cancer, 
combining the Greek words "carcinoma" and "cancer." The term 
"karakinos" is used for a tumor. Cancer comes to be the second most 
significant source of death in humans after cardiovascular disease. 
In both developed and developing countries, cancer is an unusual 
common health complication. Every year, an estimated 10.9 million 
new cancer cases, 6.7 million deaths, and 24.6 million human living 
with different types of cancer globally [1]. Because of late 
observation and low treatment effectiveness, cancer has developed 
resistance to the chemotherapeutic drug and unsatisfactory 
treatment. Radiation therapy or chemotherapy causes side effects 
like sickness, exhaustion, hair loss, vomiting, depression. It also 
affects the immunological system, kidney, urinary tract, 
gastrointestinal organs, neurologic and psychological changes [2].  
Plants fulfill our basic needs to continue life and provide natural 
products that help in curing disease. In the traditional system like 
Ayurveda, Unani plants are used as medicines for primary health care 
and provide many novel compounds used for preventing and curative 
treatment to modern science [3]. In addition, researchers in developing 
countries have discovered plant species with anticancer properties that 
have been used in herbal medicine. Moreover, medicinal plants are less 
expensive than current drugs and have no toxic effect [4].  
Compounds isolated from plants play a different role in cancer 
medication; for example, Epipodophyllotoxin, camptothecin, 
combretastatin, taxol and vinca alkaloids. Vindesine (VDS) and 
vinorelbine (VRLB) are vinca alkaloids that are semi-synthetic 
analogs. The vinblastine, vincristine, and vinca alkaloids are 
chemotherapeutic drugs, were isolated from Catharanthus roses [5].  
Natural phytochemicals used as cancer chemo-inhibitory and 
therapeutic substance  
Phytochemicals are active compounds isolated from various 
medicinal plants that have been found to have chemotherapeutic 
effects on cancer cell lines. Phytochemicals act on metabolic 
pathways and inhibit tumor growth, cancer cell development, and 
replication through various mechanisms [6]. 
Apigenin  
Apigenin is a flavonoid compound that naturally originates in many 
plants and helps suppress HeLa cells multiplication. Apigenin has 
chemo-preventive and anti-cancerous properties. The ERK/AP-1/COX-2 
pathway was inhibited by apigenin, which inhibited COX-2 activity in 
PMA-induced breast cancer cells. Apigenin suppresses Helicobacter 
pylori-induced inflammation. It promotes IKB expression in gastric 
cancer cells while suppressing COX-2 and NF-kB activity [7]. In prostate 
cancer cells of human, apigenin decreased the activity of NF-kB and its 
responsive genes. Apigenin inhibited the PGE2 level in colon cancer cells. 
Apigenin disrupts the leptin/leptin receptor pathway in a non-small cell 
lung cancer cell line, resulting in cell death [8]. 
Berberine 
Berberine is a plant-derived alkaloid with anticancer and chemo-
preventive properties. Clinical experiments for different disorders, 
including skin, intestine, breast, and oral cancers, are ongoing. 
Berberine inhibits several signaling cascades in colon cancer cells, 
including STAT3 and MMP2/MMP-9 [9]. COX and mTOR 
(mammalian target of rapamycin) pathways blocked by berberine. 
The various functions of berberine are arresting the cell cycle, 
inducing the apoptosis pathway, inhibiting the NF-kB pathway, and 
repressed COX-2 expression at the mRNA and protein level in colon 
cancer cells (HT-29). Berberine targets NF-kB/COX-2 and activates 
the apoptosis pathway in oral cancer cells [10]. In melanoma cells, 
berberine induces the expression of AMPK and inhibiting the ERK 
signaling pathways and COX-2 expression [11].  
Curcumin  
Curcumin is a polyphenolic compound originate from the Curcuma 
longa plant (1, 7-bis [4-hydroxy-3-methoxyphenyl]-1E, 
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6Eheptadiene-3, 5-dione). Curcumin suppresses tumor cell 
development by controlling different cell signaling pathways, 
including tumor suppressor pathway (p21, RB, p53), caspase 
activation (caspase-8, 3, 9), cell cycle (cyclin D1 expression), 
mitochondrial pathway of apoptosis, extrinsic apoptosis pathway, 
PI3-K/Akt cell survival pathway, and mitogen-activated protein 
kinase pathway [12]. In lung cancer cells, curcumin hinders the IFN-
induced activation of COX-2 and NF-kB activity. Curcumin inhibits 
IL-6, IL-1, and other pro-inflammatory mediators through an NF-kB, 
AP-1, and MAPK dependent pathway. Curcumin was discovered to 
have anti-inflammatory properties. In human prostate cancer cells, 
the proteins of Akt and mTOR pathways, their downstream targets, 
are phosphorylated by curcumin [13]. 
Epigallocatechin-3-gallate  
EGCG is a polyphenolic compound in green tea; it is also found in 
small amounts in white and black teas. It has a chemo-preventive 
activity against different cancer by targeting multiple pathways. 
Anti-cancer effect of EGCG shown in various cancer like brain, 
prostate, cervical, and bladder [14]. In vitro, EGCG prevented skin 
cancer cells. EGCG slows down the Bcl-xL and its antiapoptotic 
protein activity. COX-2 is repressed by EGCG, which inhibits by 
blocking the PI3K/AKT pathway. EGCG inhibits its gene products 
such as VEGEF and c-Myc. EGCG suppressed cell emigration in 
melanoma cells [15].  
Fisetin  
Fisetin is present in onions, strawberries, persimmons, apples, and 
cucumbers. It is an anti-inflammatory compound with anticancer 
effects. Fisetin prevents carcinogenesis in HCT-116 cells [16]. fisetin 
inhibits the COX-2/iNOS and NF-kB signaling pathways in skin 
cancer. Fisetin inhibited adherence, emigration, and aggression by 
lowering the amount of nuclear factor kappa B (NF-kB) and 
activator protein-1 (AP-1). Fisetin inhibited cell viability by causing 
arrest in the G1-phase of the cell cycle and disrupting Wnt/catenin 
signaling in lung cancer cells [17]. 
Genistein  
Fava beans, coffee, lupine, kudzu, and soybeans contain genistein, a 
form of isoflavone. Antiangiogenic, antioxidant, and anthelmintic 
properties have been discovering in genistein. Genistein inhibits 
DNA topoisomerase II activity and interrupts the activity of the 
tyrosine kinase enzyme [18]. Genistein has been indicating to be 
involved in the medication of leukemia in in vivo and in vitro 
research. Genistein induces the apoptosis pathway and inactivates 
NF-kB in a lung cancer cell line (H460). In addition, genistein's 
activation of the cell cycle is interrupted in breast cancer cells [19]. 
Kaempferol  
Brussels sprouts, broccoli, grapefruit, witch hazel, tea, apples, and 
other plants contain the flavonoid kaempferol. It has been used in 
the medication for lung and pancreas cancer. It has been studied for 
its antiangiogenic activity, antitumor, and free-radical scavenging 
properties. Kaempferol is a flavonoid with antitumor, antioxidant 
properties, and also capacity to cause apoptosis in cancer cells [20]. 
Kaempferol inhibits CDK1 and thus prevents the G2/M stage of the 
cell cycle in human breast cancer cells. In MCF-7 cells, kaempferol 
effectively induced PARP cleavage, accompanied by a reduction in 
Bcl2 protein expression and multiplied in Bax protein expression 
[21]. As an aryl hydrocarbon receptor (AhR) blocker, kaempferol 
inhibits the PI3K-Akt pathway, which may be helpful in the 
treatment of esophageal cancer [22]. 
Lycopene  
Lycopene is a carotenoid with anti-cancer properties and can be 
found in onions, red carrots, red papayas, and watermelons. Foods 
rich in lycopene, such as tomatoes, can slow down the possibility of 
prostate cancer. Lycopene has been appearing to have antioxidant 
and chemo-inhibitory effects in prostate cancer. Lycopene is poorly 
soluble in water but highly soluble in organic solvents. However, 
cancer-preventive enzymes, including phase II detoxification 
enzymes, are responsible for their anti-cancer properties. Lycopene 
has been appearing to have antioxidant and antimutagenic activity. 
In addition, lycopene protects the body from chemical toxicity [23].  
Quercetin  
Quercetin is a flavonoid. It is found in licorice leaves and fruits that 
have anti-cancer, anti-inflammatory, and polyphenol properties. 
Quercetin has anti-estrogenic effects, which slow down metastasis of 
breast cancer cells [24]. Quercetin controls cancerous cell 
development by stimulating tumor suppressor genes, initiating 
apoptosis pathways, and slowing down angiogenesis. Quercetin 
inhibited proliferation, reduced PGE2 levels, and increased 
apoptosis in HCA-7 human colon cancer cells during colon 
carcinogenesis [25]. 
Resveratrol  
Resveratrol, a polyphenolic molecule, is found in grapes, peanuts, 
red wine, dark berries, and other plants [26]. Many research studies 
conducted over the previous decade have appeared that resveratrol 
can hinder or delay the enlargement of disorders like cancer. It has 
chemoprevention capacity against many stages of cancers, such as 
beginning, development and progression. Resveratrol caused COX-2 
intranuclear aggregation in breast cancer cells and allowed COX2 
with Ser15-phosphorylated p53. In colon epithelial cells (HT-29), 
resveratrol suppressed the synthesis of Prostaglandin E2 (PGE2) by 
inhibiting COX-2 enzyme activity [27]. Resveratrol inhibits NF-kB 
function, blocks tumor necrosis factor, increases COX-2 activity and 
increases the immunoregulatory cytokines in liver cells. Resveratrol 
suppresses the development of breast cancer by inhibiting IkB 
kinase/NF-kB signaling and induces the expression of COX-2. 
Resveratrol also activates the tumor suppressor gene p53 [28]. 
Ursolic acid  
Ursolic acid, a natural triterpenoid compound found in plants, is 
being investigated as a cancer treatment agent. Ursolic acid stops 
cancer from spreading by blocking many signaling pathways [29]. 
For example, ursolic acid downregulates COX-2 activity and cleaved 
poly (ADP-ribose)-polymerase, which activates the apoptosis 
pathway in liver cancer cells (HepG2) [30]. In addition, ursolic acid 
inhibits cellular growth, increases apoptosis, and stops the cell cycle 
in gastric cancer cells [31].  
Molecular-level attack for natural chemo-inhibitory substances 
Apoptosis  
 
Fig. 1: In various cancers, phytochemicals activate the 
mechanism of the apoptosis pathway 
 
The two most general types of cell death are necrosis and apoptosis. 
External damage, the disappearing of the plasma membrane or its 
biochemical supports causes necrosis or cell death. Uncontrollable 
cell development and decreased apoptosis are a marker of cancer. 
Programmed cell death via apoptosis cascade is necessary for the 
proper development of multicellular organisms. The morphological 
and biochemical changes in the apoptosis pathway are chromatin 
condensation, inter nucleosomal DNA fragmentation, the origination 
of apoptotic bodies, and cell shrinkage [32]. Apoptosis can destroy 
genetically modified, pre-cancerous, or cancerous cells. Several 
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natural plant compounds were originally developed as antiviral or 
anti-inflammatory agents. Still, as our perception of cancer 
mechanisms improves, the antitumor properties of different 
phytochemicals are becoming more commonly accepted and used 
[33]. In various cancer cells, EGCG can increase the apoptosis pathway 
and inhibit the cell cycle. These effects of EGCG in cell lines were in 
millimolar and micromolar concentrations [34]. Quercetin prevents 
cellular proliferation by inducing the intrinsic pathway of apoptosis in 
different cancer. It enhanced the activity of the pro-apoptotic Bcl-2 
class of proteins and triggered caspase-9 and caspase-3 but not 
caspase-8 [35]. Red wine contains resveratrol, which is an antioxidant. 
It also decreased the activity of antiapoptotic protein Bcl-2 while 
increasing the pro-apoptotic Bcl-2 class. The Bcl-2 class contains Bid, 
Bax, Bad, and Bak proteins. In BGC-803 cancer cells, ursolic acid 
promotes DNA fragmentation, upregulating caspase3,-8, and-9 and 
downregulating Bcl-2 expression [fig. 1] [36]. 
Cell cycle  
 
Fig. 2: Mechanisms of cell cycle prevent initiate by 
phytochemicals in different cancer 
 
Cell growth and proliferation are tightly controlled processes in 
normal cells, and cell cycle dysregulation can result in unregulated 
cell proliferation and contribute to the malignant phenotype of 
tumor cells [37]. Cancer cells lack cell cycle regulation. Cell cycle 
checkpoints regulate cell growth, differentiation of cells, DNA 
replication, and apoptosis. Many phytochemicals have been 
occurring to hinder cancer cell development by controlling cell cycle 
proteins. Additionally, cell cycle checkpoints G1/S and G2/M are 
essential targets in cell cycle regulation [38].  
Curcumin caused G2/M and G1/S phase in HOS cells to prevent D1 
cyclin, cdc2, and cyclin B1 downregulation. Quercetin arrests G2/M by 
upregulating p73, p21 and waf1 while downregulating cyclin B1 in a 
human cancer cell line. Resveratrol promotes cell cycle inhibition and 
aggregation of cells in the G0–G1 phase in Pancreatic cancer cells. 
Resveratrol arrests cell cycle in G2-M and S phases and degradation in 
pancreatic cancer cells [39]. Apigenin inhibits Huh7 cell development, 
initiates the G2/M cell cycle prevention, and increases the rate of the 
apoptosis pathway. Apigenin prevented the enlargement of leukemia 
cells by allowing them to join the G2/M phase (myeloid HL60 cells) 
and the G0/G1 phase (non-myeloid HL60 cells, erythroid TF1 cells). In 
multiple myeloma cells, isothiocyanates promote cell cycle prevention 
in the G2/M phase and phosphorylation of conserved serine residue in 
the histone H3 [40]. 
JAK-STAT pathway 
The JAK-STAT (Janus kinase, signal transducer, and activator of 
transcription) pathway controls gene expression during initiation, 
enlargement, migration, and apoptosis [41]. STAT proteins were 
originally identified as cytoplasmic transcription factors, only 
translocated to the nucleus upon Jak-mediated phosphorylation and 
dimerization. When epidermal growth factors and cytokines 
interact, they generate homodimers or heterodimers that move to 
the nucleus of the cell and regulate genes [42]. The anti-apoptotic 
and proliferative properties of STAT3 in cancer cells have been 
connected to a poor prognosis. Stat3 dysregulation has been 
connected to increased breast cancer cell enlargement, survival, and 
metastasis. In myeloma, the Bcl-xL and Mcl-1 are anti-apoptotic 
proteins that were overexpressed in myeloma cells where integral 
Stat3 activity was promoted by Interleukins [43]. By reducing VEGF 
and Stat3 activation, epigallocatechin gallate reduces gastric cancer 
origination and angiogenesis. In hypopharynx carcinoma and breast 
cancer cells in human, epigallocatechin gallate slows down Stat3 
stimulation [44]. Cu (2+)-oxidized LDL-induced endothelial 
apoptosis was reduced by quercetin through the Jak2-Stat3 
pathways. In vitro treatment of activated T cells with quercetin 
inhibited IL-12-induced tyrosine phosphorylation of Jak2, Tyk2, 
Stat3, and Stat4, which results in IL-12-induced T cell proliferation 
and Th1 differentiation [fig. 3] [45].  
MAPK pathway  
Mitogen-activated protein kinase (MAPK) is particular to 
serine/threonine kinases that include JNK, ERK (extracellular 
regulated kinase), and p38. They control several processes like cell 
development and enlargement of cells by transferring cell signals to 
the nucleus. Transmitting cell signals to the nucleus affects gene 
expression that controls cell processes like cell development, 
differentiation, and multiplication [46]. The epidermal growth factor 
receptor (EGFR), estrogen receptor (ER), and tumor necrosis factor-
alpha (TNF) are the most considerable downstream effectors. 
Components of MAPK pathways, for example, PI3K, Ras, and Akt, are 
mutated in human cancer. Raf-mediated chemotherapeutic drug 
resistance induces paclitaxel in breast cancer cells. B-Raf has been 
occurring to evolve in cancer such as thyroid and breast cancer. 
Curcumin down regulates EZH2 by activating three important 
members of the mitogen-activated protein kinase (MAPK) pathway: 
c-Jun NH2-terminal kinase (JNK), extracellular signal-regulated 
kinase (ERK), and p38 kinase [47]. Ursolic acid suppresses the 
EGFR/MAPK pathway, slows down the enlargement of colon cancer 
cells, and activates the apoptosis pathway. In osteosarcoma cells, 
ursolic acid activates the MAP kinase pathway, inducing caspase-
dependent apoptosis, significantly inhibited by ERK1/2 inhibitor 
treatment [fig. 3] [48]. 
NF-kB pathway  
The transcription factors are related to cancer growth and control a 
different cellular cascade in the disease. NF-kB inducers include 
tumor necrosis factor-alpha, lipopolysaccharide, reactive oxygen 
species (ROS), and Interleukin beta [49]. Rel/NF-kB transcription 
complexes are found in an inactivated state in the cytoplasm of most 
cells, where they are attached to an inhibitor (IkB). Many stimuli can 
rapidly activate these transcription complexes from their inhibitors 
and allowing them to translocate to the nucleus [50]. The 
transcription factor NF-kB controls the expression of genes 
impenetrable in cancer invasion, angiogenesis, and metastasis. As an 
effect, inhibitors of NF-kB activity have been occurring to be helpful 
in cancer medication [51]. 
 
 
Fig. 3: Effect of phytochemicals on signaling pathway in 
different cancer 
 
Resveratrol suppressed the NF-kB-regulated gene, inhibiting 
apoptosis and preventing caspase-3 activation. Tumor necrosis 
factor promotes phosphorylation of the NF-kB. Resveratrol inhibits 
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TNF-promoted phosphorylation and nuclear transfer of the NF-kB 
p65 subunit [52]. Curcumin inhibits the transcription factor NF-kB 
and slows down the phosphorylation of IKB alpha. NF-kB initiated 
the apoptosis pathway and repressed the IKB kinase, preventing 
proliferation [fig. 3] [53].  
CONCLUSION  
Major cancer therapeutics are radiation therapy and chemotherapy, 
which causes severe side effects such as hepatic toxicity, nausea, 
vomiting, etc. Natural plant products can lower the toxicity of 
radiation therapy and chemotherapy. This review gives information 
about different phytochemicals and their anticancer activity by 
targeting apoptosis, cell cycle, JAK-STAT, MAPKs, and NF-kB 
activation in vitro research.  
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